DN STRIM

Scientific Training for Post-Transitional Modification Detection in Cancer Screening

[DN STRIM @DNSTRIM]

Prostate cancer is the most commonly diagnosed cancer in men, yet its current blood tests often deliver false positives or miss cancer entirely. We show that simple serum tests for PSA Glycan Score 100% accurately diagnoses and prognoses prostate cancer. https://t.co/Wy56E6shIB

[DN STRIM @DNSTRIM]

📢 We're hiring! 🚀 Join our cutting-edge project as a PhD student—13 positions available! Don't miss this opportunity to work at the forefront of research. Apply now! 🔬🎓 #PhD #Hiring #ResearchOpportunity

[DN STRIM @DNSTRIM]

The STRIM consortium unites top experts in bioinformatics, biomarker discovery, nanotech, biosensors, cancer research & health tech from 6 universities, 2 companies, 3 research centers & 2 hospitals. Advancing innovation for better health! 🔬✨ #Biotech #HealthTech #Innovation

[DN STRIM @DNSTRIM]

STRIM Training Network delivers fast and accurate bioelectronic tools for cancer screening that use advanced molecular receptors & nanotechnologies for detection of aberrant post-translational modifications of proteins & nucleic acids as biofluid markers of cancers.

[DN STRIM @DNSTRIM]

DN-STRIM is landed!